EGFR and skin squamous cell carcinoma: Although there have not been any studies to date that have investigated the efficacy of EGFR inhibitors specifically in immunosuppressed patients, a recent retrospective study examined the response to cetuximab in patients with cSCC who were not candidates for immunotherapy or were refractory to immunotherapy [66].